Adv Pharm Bull. 2019;9(1): 56-63.
doi: 10.15171/apb.2019.007
PMID: 31011558
PMCID: PMC6468229
Scopus ID: 85065986839
  Abstract View: 777
  PDF Download: 701

Research Article

The Effect of Mesenchymal Stem Cells on the Expression of IDOand Qa2 Molecules in Dendritic Cells

Ali Moravej 1 ORCID logo, Amin Kouhpayeh 1 ORCID logo, Bita Geramizadeh 2, Negar Azarpira 2 ORCID logo, Ramin Yaghobi 2 ORCID logo, Yaser Mansoori 1 ORCID logo, Mohammad-Hossein Karimi 2* ORCID logo

1 Noncommunicable Diseases Research Centre, Fasa University of Medical Sciences, Fasa, Iran.
2 Transplant Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.


Purpose: Mesenchymal stem cells (MSCs) have been shown to reduce the activity of immunecells, including dendritic cells (DCs). But the exact mechanism of mesenchymal inhibitionof DCs is still unknown. In this study, the effect of mesenchymal cells on the expression ofindoleamine dioxygenase (IDO) and Qa2 molecules in DCs was evaluated.Methods: MSCs and DCs were respectively isolated from the bone marrow and spleen of BALB/cmice. Then DCs were co-cultured with MSCs in the present and absence of lipopolysaccharides(LPS). Then the expression of mRNA and protein of IDO and Qa2 molecules were investigatedin DCs that were treated with MSCs.Results: The expression of IDO and Qa2 mRNA in DCs that were treated with MSCs did notsignificantly differ from the control group. The expression of IDO protein in DCs that were coculturedwith MSCs (in 1:10 and 1:50 ratios) in absence of LPS was increased, although theywere not statistically significant (P values: 0.24 and 0.18, respectively). The expression of Qa2protein in DCs that were co-cultured with MSCs (in 1:10 and 1:50 ratios) in presence of LPS wasincreased, although they were not statistically significant (P-values: 0.09 and 0.33, respectively).Conclusion: Our results denied the possibility that MSCs led to the induction of tolerogenic DCsby increasing the expression of the IDO and Qa2 immunomodulatory molecules.
Keywords: MSCs, DCs, IDO, Qa2, Immunomodulation
First Name
Last Name
Email Address
Security code

Abstract View: 778

Your browser does not support the canvas element.

PDF Download: 701

Your browser does not support the canvas element.

Submitted: 02 Oct 2018
Revision: 10 Dec 2018
Accepted: 20 Dec 2018
ePublished: 21 Feb 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)